Mirum Pharmaceuticals (MIRM) EPS (Basic) (2019 - 2026)
Mirum Pharmaceuticals' quarterly EPS (Basic) came in at -$13.43 in Q1 2026, down 4376.67% year-on-year from $0.31 in Q1 2025, and down 11091.67% quarter-over-quarter from -$0.12 in Q4 2025.
Mirum Pharmaceuticals has reported EPS (Basic) for 8 years, with the latest figure at -$13.43 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 4376.67% year-over-year to -$13.43; the trailing twelve-month figure through Mar 2026 stood at -$13.61 (down 745.34% YoY), and the FY2025 full-year result was -$0.47, up 74.59% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$13.43, down from -$0.12 in the prior quarter.
- The five-year high for EPS (Basic) was $0.06 in Q3 2025, with the low at -$13.43 in Q1 2026.
- Average EPS (Basic) over 5 years is -$1.4, with a median of -$0.57 recorded in 2023.
- Year-over-year, EPS (Basic) soared 120.0% in 2025 and sank 4376.67% in 2026.
- Tracing MIRM's EPS (Basic) over 5 years: stood at -$0.98 in 2022, then climbed by 26.53% to -$0.72 in 2023, then surged by 31.94% to -$0.49 in 2024, then soared by 75.51% to -$0.12 in 2025, then plunged by 11091.67% to -$13.43 in 2026.
- The last three EPS (Basic) figures came in at -$13.43 (Q1 2026), -$0.12 (Q4 2025), and $0.06 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.55 |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -13.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.43 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -0.49 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.52 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -0.72 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -1.94 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -0.98 |
| Sep 30, 2022 | -1.02 |
| Jun 30, 2022 | -0.84 |
| Mar 31, 2022 | -1.17 |
| Dec 31, 2021 | 1.91 |
| Sep 30, 2021 | -1.55 |
| Jun 30, 2021 | -1.45 |
| Mar 31, 2021 | -1.68 |
| Dec 31, 2020 | -1.44 |
| Sep 30, 2020 | -0.86 |
| Jun 30, 2020 | -0.93 |
| Mar 31, 2020 | -0.86 |
| Dec 31, 2019 | -0.11 |
| Sep 30, 2019 | -0.84 |
| Jun 30, 2019 | -5.31 |
| Mar 31, 2019 | -2.37 |